The use of serotonin reuptake inhibitors increases the risk of bleeding in patients with assist devices.

Bleeding events in heart failure patients occur frequently after VAD implantation. Patients with SRI medication were at increased risk of bleeding. The indication and use of SRI, therefore, should be considered carefully.